ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 6,420.00
+390.00 (6.47%)
At close: Jun 29, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 131.61 billion as of June 29, 2026. Its market cap has increased by 112.75% in one year.
Market Cap
131.61B
Enterprise Value
94.31B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,420.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 131.61B, a decrease of -76.55%. That is a compound annual growth rate of -25.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 131.61B | -34.15% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 167.70B |
| Y-Biologics | 165.59B |
| Genome & Company | 161.29B |
| Bio Solution | 152.25B |
| Prestige Biologics | 151.23B |
| ISU Abxis | 129.26B |
| TiumBio | 110.69B |
| NovMetaPharma | 107.87B |